Overhauling Compliance and GMPs

FDA's newly launched risk-based approach to GMP regulation spurs signficant changes in the agency's approach to inspection processes, postapproval changes, and 21 CFR Part 11 enforcement.

Related Content:

Regulatory/GMP ComplianceQuality SystemsRegulatory WatchPharmaceutical Technology-04-02-2003

EC Approves Vabysmo for Two Leading Causes of Vision Loss

Congress Slated to Reauthorize User Fees Without FDA “Improvements”

The Manufacturing Edge on Path to Market